ICD-10-CM Billable Code

M60.89

Other myositis, multiple sites

Clinical Classification Guidelines

Medical Intelligence & Overview

Other myositis, classified under ICD-10 code M60.89, refers to an inflammatory condition affecting various muscles throughout the body. Unlike specific types of myositis that target particular muscle groups, this category encompasses cases with widespread muscle inflammation in multiple areas. Myositis can cause muscle weakness, pain, and fatigue, impacting daily life and overall health. Recognizing the signs, causes, and available diagnostic options helps individuals and healthcare providers manage this condition effectively.

Causes & Symptoms

Clinical Causes: Autoimmune responses where the body's immune system mistakenly attacks muscle tissue. Genetic predispositions that may increase susceptibility to inflammatory muscle conditions. Infections caused by bacteria, viruses, or parasites that trigger muscle inflammation. Drug-induced myositis, resulting from reactions to certain medications such as statins or other drugs. Exposure to environmental toxins or chemicals that may provoke inflammatory responses in muscle tissues. Other underlying medical conditions that can predispose to muscle inflammation.

Key Symptoms: Progressive muscle weakness, often affecting larger muscle groups such as shoulders, hips, and thighs. Muscle pain and tenderness, which can be persistent or episodic. Fatigue that worsens with physical activity and improves with rest. Swelling or inflammation in affected muscles, sometimes visible or palpable. Difficulty performing daily tasks like climbing stairs, lifting objects, or raising arms. Possible skin rashes or signs if associated with specific types of myositis, such as dermatomyositis. Occasional joint pain or swelling in cases where the disease overlaps with other autoimmune conditions.

Diagnostic & Treatment

Diagnosis Path: Diagnosing other myositis involves a combination of clinical evaluation and various tests. Healthcare providers typically perform a physical examination to assess muscle strength and identify areas of tenderness or swelling. Laboratory tests usually include blood work to detect elevated muscle enzymes like creatine kinase (CK), which indicate muscle damage. Imaging studies such as MRI scans can reveal inflammation within muscles. Electromyography (EMG) may be conducted to evaluate electrical activity in muscles. A muscle biopsy might be recommended to confirm inflammation and exclude other causes. Additional tests can include antibody panels to detect specific autoimmune markers and rule out related connective tissue diseases.

Treatment Protocols: Corticosteroids such as prednisone to quickly suppress inflammation. Immunosuppressive medications like methotrexate or azathioprine to control immune response over the longer term. Physical therapy to maintain muscle strength and prevent contractures or deformities. Pain management strategies, including nonsteroidal anti-inflammatory drugs (NSAIDs). Monitoring and adjusting treatments based on response and side effects, guided by healthcare providers. Addressing any underlying causes if identified, such as infections or medication reactions. Lifestyle modifications, including balanced activity and rest periods, to manage fatigue and muscle strain.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M60.89 a billable ICD-10 code?
Yes, M60.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M60.89?
Clinical documentation must specify the nature of Other myositis, multiple sites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference